No desensitization of the growth hormone (GH) response between GH-releasing peptide-2 and GH-releasing factor in calves.
We investigated the desensitization caused by growth hormone (GH)-releasing peptide-2 (D-Ala-D-beta Nal-Ala-Trp-D-Phe-Lys-NH2; GHRP-2) in vivo using calves. The GHRP-2 (12.5 micrograms.kgBW-1.h-1) or GH-releasing factor (GRF; .125 microgram.kgBW-1.h-1) were infused for 180 min into four calves, each followed by either GHRP-2 (12.5 micrograms/kg BW) or GRF (.125 microgram/kg BW) injection after 60 min. All treatments were given to all of the calves. The continuous infusion of GHRP-2 did not attenuate the GH secretion caused by a GRF bolus, and vice versa. Continuous exposure to GHRP-2 attenuated the GH secretion caused by a GHRP-2 bolus. In an additional experiment, two repetitive injections of GHRP-2 (12.5 micrograms/kg BW) at 1-, 2-, 3-, or 4-h intervals were administered. Attenuation of the GH response caused by GHRP-2 was maintained until 4 h. These results suggest that GHRP-2 is not cross-desensitized with GRF and that the mechanisms by which they cause GH release may be different in calves.
Roh
S G
SG
Department of Animal Science, Obihiro University of Agriculture and Veterinary Medicine, Japan.
He
M L
ML
Matsunaga
N
N
Hidaka
S
S
Hidari
H
H
D000818:Animals; D019540:Area Under Curve; D002417:Cattle / Q000097:blood* / Q000502:physiology; D004305:Dose-Response Relationship, Drug; D013006:Growth Hormone / Q000097:blood*; D013007:Growth Hormone-Releasing Hormone / Q000008:administration & dosage / Q000494:pharmacology*; D006728:Hormones / Q000008:administration & dosage / Q000494:pharmacology*; D007262:Infusions, Intravenous / Q000662:veterinary; D007267:Injections / Q000662:veterinary; D009842:Oligopeptides / Q000008:administration & dosage / Q000494:pharmacology*; D011863:Radioimmunoassay / Q000662:veterinary; D013997:Time Factors
D006728:Hormones; D009842:Oligopeptides; D013006:Growth Hormone; D013007:Growth Hormone-Releasing Hormone; C091874:growth hormone-releasing peptide-2